Clarithromycin reduces prednisolone requirements for treatment of intractable Takayasu arteritis

Clinical and Experimental Rheumatology

Volumn 22, Issue 6 SUPPL., 2004, Pages

  Yamaguchi, Koushi ^a   Murashima, A ^a   Yamamoto, Y ^b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; METHOTREXATE; PREDNISOLONE; STEROID; ANTIINFECTIVE AGENT; GLUCOCORTICOID; C REACTIVE PROTEIN;

ADULT; ANAMNESIS; AORTA ARCH SYNDROME; CASE REPORT; DISEASE COURSE; FEMALE; FIBROSIS; GIANT CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LETTER; LEUKOCYTOSIS; LYMPHOCYTIC INFILTRATION; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; TREATMENT PLANNING; WASTING SYNDROME; CAROTID ARTERY; DRUG COMBINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SUBCLAVIAN ARTERY; TREATMENT OUTCOME; AORTIC ARCH SYNDROME; BACKACHE; COMPUTER ASSISTED TOMOGRAPHY; WEIGHT REDUCTION;

ADULT; ANTI-BACTERIAL AGENTS; CAROTID ARTERIES; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; PREDNISOLONE; SUBCLAVIAN ARTERY; TAKAYASU'S ARTERITIS; TREATMENT OUTCOME;

EID: 23944503595     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. JOHNSTON SL, LOCK RJ, GOMPLES MM: Takayasu arteritis (review). J Clin Pathol 2002; 55: 481-6.
2. MORIWAKI R, NODA M, YAJIMA M, SHARMA BK, NUMANO F: Clinical manifestations of Takayasu arteritis in India and Japan-new classification of angiographic findings. Angiology 1997; 48: 369-79.
3. ISHIKAWA K: Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 1978; 57: 27-35.
4. DAL CANTO AJ, VIRGIN HW 4th: Animal models of infection-mediated vasculitis: implications for human disease. Int J Cardiol 2000; 75 (Suppl. 1): S37-45; discussion S47-52.
5. LEINONEN M, SAIKKU P: Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002; 2: 11-7.
6. KALAYOGLU MV, LIBBY P, BYRNE GI: Chlamydia pneumonias as an emerging risk factor in cardiovascular disease. JAMA 2002; 288: 2724-31.
7. IANARO A, IALENTI A, MAFFIA P el al.: Antiinflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000; 292: 156-63.
8. SAVIOLA G, ABDI AL, ROSSINI P el al: Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. Clin Exp Rheumatol 2002; 20: 373-8.
9. ZALEWSKA-KASZUBSKA J, GORSKA D: Antiinflammatory capabilities of macrolides. Pharmacol Res 2001; 44: 451-4.